Bill
H 2212
Overview: H 2212, An Act relative to patient opioid notification, is currently scheduled for a hearing on 11/03/2025 from 01:00 PM-05:00 PM in A-2. The bill was introduced on Febru
Overview: H 2212, An Act relative to patient opioid notification, is currently scheduled for a hearing on 11/03/2025 from 01:00 PM-05:00 PM in A-2. The bill was introduced on February 27, 2025.
Purpose and Intent: The main goal of this bill is to improve patient awareness and understanding of the risks associated with opioid prescriptions. The legislation aims to ensure that patients are fully informed about the potential for addiction and overdose when being prescribed opioid medications.
Key Provisions:
- Requires healthcare providers to have a discussion with patients about the risks of opioid use and obtain written acknowledgment prior to prescribing opioids
- Mandates the inclusion of a standardized opioid risk notification in all opioid prescriptions
- Directs the Department of Public Health to develop educational materials and resources for patients on opioid safety
Affected Parties and Impacts: This bill would impact all patients who are prescribed opioid medications, as well as healthcare providers responsible for prescribing and dispensing these drugs. The increased patient education and notification requirements are intended to help reduce opioid misuse and overdose.
Procedural and Timeline Considerations: The bill is currently scheduled for a public hearing on November 3, 2025. After the hearing, it will proceed through the standard legislative process, including potential amendments, committee votes, and floor votes in both chambers before potentially being signed into law.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
